Steatorrhea medical therapy

Jump to navigation Jump to search

Steatorrhea Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Steatorrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Steatorrhea medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Steatorrhea medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Steatorrhea medical therapy

CDC on Steatorrhea medical therapy

Steatorrhea medical therapy in the news

Blogs on Steatorrhea medical therapy

Directions to Hospitals Treating Steatorrhea

Risk calculators and risk factors for Steatorrhea medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]


Overview

Medical Therapy

Management of steatorrhea include treatment of underlying etiology, control of diarrhea and correction of nutritional deficiencies.

Correction of Nutritional Deficiencies

  • Oral supplementation with vitamins and minerals is usually well tolerated in patients who are are undergoing specified treatment for underlying etiology.
  • Rapid recovery following the identification of a nutritional deficiency can be achieved by supplementation with 5 to 10 times the Recommended Dietary Allowance.
    • Preferred regimen (1) : Vitamin A 40,000 to 50,000 units q12h
      • Note : Maintenance: 8000 to 20,000 units/day (dosage ≥15,000 units can be teratogenic)
    • Preferred regimen (2) : Vitamin D3 (cholecalciferol) 30,000 to 50,000 units q24h

Antidiarrheal agents

Bile acid binding resins

  • Preferred regimen (1) : Cholestyramine 4 g three times daily
  • Preferred regimen (1) : Colestipol granules 5 to 10 g three times daily
    • Note: Administer ≥1 hour before or >4 hours after other drugs to prevent decreased absorption of other drugs.

Pancreatic enzymes

  • Preferred regimen (1) : Pancrelipase delayed-release capsules (Creon minimicrospheres)
  • Preferred regimen (1) : Pancrelipase tablets and powder (Viokase) 1 g
  • (equivalent to 20,000 units lipase component) with meals
    • Note:  Approximately 30,000 units (90,000 USP) (lipase component) with each meal

Management of Underlying Etiologies

  • For a detailed explanation of management of Crohn's disease click here
  • For a detailed explanation of management of celiac disease click here
  • For a detailed explanation of management of gallstones disease click here
  • For a detailed explanation of management of cystic fibrosis disease click here
  • For a detailed explanation of the management of small bowel bacterial overgrowth syndrome click here

References

Template:WS Template:WH